use of bone powder in gum based vertical bone loss of teeth

efficacy of autologous concentrated growth factor enriched bone graft matrix in magnification assisted treatment of periodontal intrabony defects : A randomized controlled clinical and radiographic study

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/04/013207

Enrollment

Registered

2018-04-12

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- moderate to severe periodontitis

Interventions

Intervention1: concentrated growth factor enriched with bone graft: concentrated growth factor will be prepared by using sacco s protocol. the sample of blood will be centrifuged at variable rpm for 1

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presence of atleast one tooth on each side of the mouth with probing depth and clinical attachment level of greater than or equal to 5mm 3. Radiographic evidence of interproximal introsseous defect depth of greater than or equal to 3mm

Exclusion criteria

Exclusion criteria: 1. Patients with poor oral hygiene 2. Pregnancy and lactating women 3. Patients on continuous antibiotics antiinflammatory and immunosuppresants in last 6 months 4. Patients with systemic diseases 5. Smokers 6. Patients with unmanageble occlusal dysfunction 7. Patints with bleeding disorders and hematologic diseases

Design outcomes

Primary

Measure	Time frame
1. Amount of bone fill 2. Percentage of bone fill 3. Probing depth 4. Clinical attachment levelTimepoint: Zero and Six months	—

Secondary

Measure	Time frame
1. Plaque index 2. Gingival indexTimepoint: Zero and six months	—

Countries

India

Contacts

Public ContactSUNEETHA K

vishnu dental college

konerusuneetha@gmail.com9290574051

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026